Wedlake Bell advises the shareholders of Katalyst Diagnostics on the sale of Katalyst to Cruinn Diagnostics
Katalyst Diagnostics is a UK-based point-of-care diagnostics business specialising in premium and innovative diagnostic solutions for healthcare organizations and clinical professionals, providing access to advanced point-of-care technologies in areas including haematology, clinical chemistry and antipsychotic drug monitoring. Katalyst Diagnostics supports
More about Wedlake Bell advises the shareholders of Katalyst Diagnostics on the sale of Katalyst to Cruinn Diagnostics